ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,282 | -11.7% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $39,962 | -14.7% | 1,300 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $46,839 | -12.9% | 1,300 | -4.4% | 0.01% | -11.1% |
| Q4 2022 | $53,747 | -0.5% | 1,360 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $54,000 | -6.9% | 1,360 | -0.3% | 0.01% | -9.1% |
| Q2 2022 | $58,000 | +13.7% | 1,364 | +4.9% | 0.01% | +22.2% |
| Q1 2022 | $51,000 | -1.9% | 1,300 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $52,000 | +10.6% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $47,000 | -11.3% | 1,300 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $53,000 | -7.0% | 1,300 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $57,000 | -12.3% | 1,300 | 0.0% | 0.01% | -17.6% |
| Q4 2020 | $65,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |